VA
LLY icon

Vident Advisory’s Eli Lilly LLY Stock Holding History

Vident Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$62.1M Buy
67,569
+8,339
+14% +$8.45M 0.53% 32
2025
Q4 		$63.7M Buy
59,230
+2,874
+5% +$2.75M 0.58% 34
2025
Q3 		$43M Buy
56,356
+6,318
+13% +$4.7M 0.41% 51
2025
Q2 		$39M Buy
50,038
+3,937
+9% +$3.06M 0.44% 50
2025
Q1 		$38.1M Buy
46,101
+13,484
+41% +$11.2M 0.56% 33
2024
Q4 		$25.2M Buy
32,617
+4,500
+16% +$3.73M 0.44% 45
2024
Q3 		$24.9M Buy
28,117
+8,586
+44% +$7.72M 0.63% 28
2024
Q2 		$17.7M Buy
19,531
+880
+5% +$704K 0.49% 38
2024
Q1 		$14.5M Buy
18,651
+1,688
+10% +$1.2M 0.3% 112
2023
Q4 		$9.89M Sell
16,963
-3,668
-18% -$2.14M 0.25% 135
2023
Q3 		$11.1M Buy
+20,631
New +$10.6M 0.34% 73

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vident Advisory's LLY Position: Q1 2026 in Review

Vident Advisory increased its Eli Lilly (LLY) stake by 14% in Q1 2026, buying an estimated $8.45M and bringing the position to 67,569 shares worth $62.1M. The position accounts for 0.53% of the portfolio, ranked #32.

Vident Advisory first reported a position in LLY in Q3 2023 and has held it in 11 quarters since. The position peaked at $63.7M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Vident Advisory held 67,569 shares of Eli Lilly worth $62.1M as of Q1 2026.
  • Vident Advisory bought 8,339 Eli Lilly shares in Q1 2026, an estimated $8.45M.
  • Eli Lilly made up 0.53% of Vident Advisory's portfolio in Q1 2026, its #32 holding.
  • Vident Advisory first reported a position in Eli Lilly in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Eli Lilly position peaked at $63.7M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.